Drug Pricing

ADAP Advocacy Report Highlights Medical Debt Crisis Despite $66 Billion 340B Drug Pricing Program

ADAP Advocacy Report Highlights Medical Debt Crisis Despite $66 Billion 340B Drug Pricing Program

ADAP Advocacy's new infographics reveal that while the 340B Drug Pricing Program has grown to $66 billion primarily benefiting hospitals, patients continue facing aggressive medical debt collection and financial hardship.

September 18, 2025
Advocacy Group Launches National Campaign to Reform 340B Drug Pricing Program

Advocacy Group Launches National Campaign to Reform 340B Drug Pricing Program

ADAP Advocacy initiates a nationwide campaign questioning the accountability and transparency of the 340B Drug Pricing Program, drawing parallels to pre-2008 financial market oversight and highlighting potential systemic issues in healthcare.

May 15, 2025